Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic associated fatty liver disease is a risk factor for chronic kidney disease
Yoshitaka Hashimoto, Masahide Hamaguchi, Takuro Okamura, et al.
Journal of Diabetes Investigation (2021) Vol. 13, Iss. 2, pp. 308-316
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
Kai En Chan, Tiffany Jia Ling Koh, Ansel Shao Pin Tang, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 9, pp. 2691-2700
Open Access | Times Cited: 190
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
Dan‐Qin Sun, Giovanni Targher, Christopher D. Byrne, et al.
HepatoBiliary Surgery and Nutrition (2023) Vol. 12, Iss. 3, pp. 386-403
Open Access | Times Cited: 55
Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 30
MAFLD: Exploring the Systemic Effects Beyond Liver.
Utkarsh Dayal, Ujjwal Soni, Sourav Bansal, et al.
Journal of Community Hospital Internal Medicine Perspectives (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Metabolic dysfunction-associated fatty liver disease: a year in review
Jawaher Alharthi, Amalia Gastaldelli, Ian Homer, et al.
Current Opinion in Gastroenterology (2022) Vol. 38, Iss. 3, pp. 251-260
Closed Access | Times Cited: 62
Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals
Jingxuan Quek, Cheng Han Ng, Ansel Shao Pin Tang, et al.
Endocrine Practice (2022) Vol. 28, Iss. 7, pp. 667-672
Closed Access | Times Cited: 52
Metabolic dysfunction–associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease
Marenao Tanaka, Kazuma Mori, Satoko Takahashi, et al.
Nephrology Dialysis Transplantation (2022) Vol. 38, Iss. 3, pp. 700-711
Closed Access | Times Cited: 38
Steatotic liver disease, MASLD and risk of chronic kidney disease
Josh Bilson, Alessandro Mantovani, Christopher D. Byrne, et al.
Diabetes & Metabolism (2023) Vol. 50, Iss. 1, pp. 101506-101506
Open Access | Times Cited: 33
Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review
Amedeo Lonardo
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 9
Metabolic Dysfunction Associated-Steatotic Liver Disease (MASLD) and Cardiovascular Risk: Embrace All Facets of the Disease
Niki Katsiki, Genovefa Kolovou, Michal Vráblík
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Closed Access | Times Cited: 1
MAFLD and CKD: An Updated Narrative Review
Alessandro Mantovani, Rosa Lombardi, Filippo Cattazzo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7007-7007
Open Access | Times Cited: 34
The association between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: A systematic review and meta-analysis
Nenny Agustanti, Nanny Natalia Mulyani Soetedjo, Fachreza Aryo Damara, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 5, pp. 102780-102780
Closed Access | Times Cited: 17
Clinical outcomes of MAFLD versus NAFLD: A meta‐analysis of observational studies
Grazia Pennisi, G. Infantino, Ciro Celsa, et al.
Liver International (2024) Vol. 44, Iss. 11, pp. 2939-2949
Open Access | Times Cited: 7
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
Eda Kaya, Yusuf Yılmaz
Therapeutic Advances in Endocrinology and Metabolism (2022) Vol. 13
Open Access | Times Cited: 25
Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis
Jianghua Zhou, Dan‐Qin Sun, Giovanni Targher, et al.
eGastroenterology (2023) Vol. 1, Iss. 1, pp. e100005-e100005
Open Access | Times Cited: 12
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Exploring Systemic Impacts and Innovative Therapies
Parag Jain, Akanksha Jain, Rohitas Deshmukh, et al.
Clinics and Research in Hepatology and Gastroenterology (2025), pp. 102584-102584
Closed Access
Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease
Weitao Su, Minhui Chen, Ling Xiao, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 16
The Inter-Organ Crosstalk Reveals an Inevitable Link between MAFLD and Extrahepatic Diseases
Tsubasa Tsutsumi, Dan Nakano, Ryuki Hashida, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1123-1123
Open Access | Times Cited: 9
The clustering of Cardiovascular, Renal, Adipo-Metabolic Eye and Liver disease with type 2 diabetes
Merlin C. Thomas
Metabolism (2021) Vol. 128, pp. 154961-154961
Closed Access | Times Cited: 20
The Impact of COVID-19 Pandemic Lockdown on the Relationship between Pediatric MAFLD and Renal Function
Maria Sole Valentino, Pierluigi Marzuillo, Claudia Esposito, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 2037-2037
Open Access | Times Cited: 6
Review on Kidney-Liver Crosstalk: Pathophysiology of Their Disorders.
Niloofar Khoshdel Rad, Zahra Heydari, Amir Hossein Tamimi, et al.
PubMed (2024) Vol. 26, Iss. 2, pp. 98-111
Closed Access | Times Cited: 2
The Role of Metabolic Dysfunction–Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study
Suosu Wei, Jian Song, Yujie Xie, et al.
JMIR Public Health and Surveillance (2023) Vol. 9, pp. e45050-e45050
Open Access | Times Cited: 6
Metabolic dysfunction-associated fatty liver disease can significantly increase the risk of chronic kidney disease in adults with type 2 diabetes
Suosu Wei, Jian Song, Yujie Xie, et al.
Diabetes Research and Clinical Practice (2023) Vol. 197, pp. 110563-110563
Closed Access | Times Cited: 5
Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes
Mohammad W. Alomari, Mamoon Ur Rashid, Pravallika Chadalavada, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 4, pp. 477-496
Open Access | Times Cited: 4
Furthering research on MAFLD: the APASL Metabolic fAtty lIver DiseasE coNsortium (MAIDEN)
Jacob George, George Lau, Takumi Kawaguchi, et al.
Hepatology International (2023) Vol. 17, Iss. 3, pp. 546-549
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top